Clinical Trials Logo
  1. Home
  2. Arthroplasty, Replacement
  3. NCT01909375
  4. Details
NCT01909375 Clinical Trial

American Joint Replacement Registry

ARTHROPLASTY, REPLACEMENT Clinical Trial

— AJRR  

Official title:
American Joint Replacement Registry

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT01909375
Other study ID # 1120353
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date August 2011
Est. completion date December 2025

Study information
Verified date February 2023
Source American Joint Replacement Registry
Contact Nathan Glusenkamp
Phone 8473844028
Email glusenkamp@aaos.org
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The American Joint Replacement Registry is a not-for-profit 501(c)(3) organization for data collection and quality improvement initiatives for total hip and knee replacements. The AJRR is a collaborative effort supported by the American Academy of Orthopaedic Surgeons (AAOS), the American Association of Hip and Knee Surgeons (AAHKS), The Hip Society, The Knee Society, hospitals, health insurers, medical device manufacturers, and contributions from individual orthopaedic surgeons.

Recruitment information / eligibility
Status Recruiting
Enrollment 500000
Est. completion date December 2025
Est. primary completion date December 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Any individual in the US undergoing total joint arthroplasty Exclusion Criteria: - None

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
United States Nathan Glusenkamp Rosemont Illinois

Sponsors (1)
Lead Sponsor Collaborator
American Joint Replacement Registry

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Other Knee Injury and Osteoarthritis Outcome Score - Joint Replacement (KOOS, JR) 12 months
Primary Health Related Quality of Life Utilization of VR-12 and/or PROMIS-10 12 months
Secondary Hip disability and Osteoarthritis Outcome Score - Joint Replacement (HOOS, JR) 12 months
See also
  Status Clinical Trial Phase
Completed NCT02728661 - Patient-Centered Weight Loss Program for Knee Replacement Patients Phase 1/Phase 2
Recruiting NCT04080401 - Effectiveness of a Novel Gaming System on Post-operative Rehabilitation Outcomes After Total Knee Arthroplasty N/A
Completed NCT02648958 - Effect of Dexmedetomidine on Ischemia-Reperfusion Injury in Lower Extremity Operations N/A
Completed NCT00846807 - Pradaxa (Dabigatran Etexilate 220 mg/q.d. in the General Population After Hip or Knee Replacement Surgery N/A
Completed NCT04372173 - An Evaluation of Clotting Factor Activity Before and After Total Hip Arthroplasty
Terminated NCT01153698 - Pradaxa (Dabigatran Etexilate) VTE Prevention After Elective Total Hip or Knee Replacement Surgery
Completed NCT01184989 - Treatment of Patients Undergoing Primary Unilateral Elective Total Knee or Hip Replacement With Dabigatran Etexilate Phase 4
Active, not recruiting NCT00114036 - Trial to Reduce Antimicrobial Prophylaxis Errors (TRAPE) N/A
Completed NCT03407885 - The Impact of Medicare Bundled Payments N/A
Completed NCT01857349 - Efficacy of Surgical Preparation Solutions in Knee Surgery N/A
Completed NCT00847301 - Pradaxa (Dabigatran Etexilate) 150 mg/q.d. in Patients With Moderate Renal Impairment After Hip or Knee Replacement Surgery N/A
Recruiting NCT04697004 - SMR Stemless Reverse vs SMR Reverse Shoulder System N/A
Completed NCT03158623 - Wound Additives in Primary Total Joint Athroplasty Phase 3